Optherion Inc.

Add-on therapies to AMD blockbuster Lucentis One Penn Plaza 35th Floor New York, NY 10119 Phone: (212) 845-8200 Web Site: www.ophthotech.com Contact: Samir Patel, MD, President & CEO Industry Segment:

Spurred by the commercial success of Lucentis, start-ups developing new therapeutics for AMD tap into a growing understanding of the pathogenesis of the disease. It has been three years since Roche

Untangling the genetics of AMD The Maritime Center 11th Floor 555 Long Wharf Drive New Haven, CT 06511 Phone: (203) 781-0072 Web Site: www.optherion.com Contact: Colin Foster, President & CEO Industry

A preview of the emerging health care companies profiled in the current issue of START-UP: Windhover’s Review of Emerging Medical Ventures . This month's profile groups: Biotechs Eye Macular Degenera